139 related articles for article (PubMed ID: 11256963)
1. Sphingosylphosphocholine is a naturally occurring lipid mediator in blood plasma: a possible role in regulating cardiac function via sphingolipid receptors.
Liliom K; Sun G; Bünemann M; Virág T; Nusser N; Baker DL; Wang DA; Fabian MJ; Brandts B; Bender K; Eickel A; Malik KU; Miller DD; Desiderio DM; Tigyi G; Pott L
Biochem J; 2001 Apr; 355(Pt 1):189-97. PubMed ID: 11256963
[TBL] [Abstract][Full Text] [Related]
2. A novel membrane receptor with high affinity for lysosphingomyelin and sphingosine 1-phosphate in atrial myocytes.
Bünemann M; Liliom K; Brandts BK; Pott L; Tseng JL; Desiderio DM; Sun G; Miller D; Tigyi G
EMBO J; 1996 Oct; 15(20):5527-34. PubMed ID: 8896446
[TBL] [Abstract][Full Text] [Related]
3. EDG3 is a functional receptor specific for sphingosine 1-phosphate and sphingosylphosphorylcholine with signaling characteristics distinct from EDG1 and AGR16.
Okamoto H; Takuwa N; Yatomi Y; Gonda K; Shigematsu H; Takuwa Y
Biochem Biophys Res Commun; 1999 Jun; 260(1):203-8. PubMed ID: 10381367
[TBL] [Abstract][Full Text] [Related]
4. A role for G protein-coupled lysophospholipid receptors in sphingolipid-induced Ca2+ signaling in MC3T3-E1 osteoblastic cells.
Lyons JM; Karin NJ
J Bone Miner Res; 2001 Nov; 16(11):2035-42. PubMed ID: 11697799
[TBL] [Abstract][Full Text] [Related]
5. Sphingosine-1-phosphate effects on guinea pig atrial myocytes: Alterations in action potentials and K+ currents.
Ochi R; Momose Y; Oyama K; Giles WR
Cardiovasc Res; 2006 Apr; 70(1):88-96. PubMed ID: 16545787
[TBL] [Abstract][Full Text] [Related]
6. Quantitative evaluation of sphingolipids using delayed extraction matrix-assisted laser desorption ionization time-of-flight mass spectrometry with sphingosylphosphorylcholine as an internal standard. Practical application to cardiac valves from a patient with Fabry disease.
Fujiwaki T; Tasaka M; Takahashi N; Kobayashi H; Murakami Y; Shimada T; Yamaguchi S
J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Feb; 832(1):97-102. PubMed ID: 16431168
[TBL] [Abstract][Full Text] [Related]
7. Identification of G protein-coupled, inward rectifier potassium channel gene products from the rat anterior pituitary gland.
Gregerson KA; Flagg TP; O'Neill TJ; Anderson M; Lauring O; Horel JS; Welling PA
Endocrinology; 2001 Jul; 142(7):2820-32. PubMed ID: 11416001
[TBL] [Abstract][Full Text] [Related]
8. Remodeling of inward rectifying K(+) currents in rat atrial myocytes by overexpression of A(1)-adenosine receptors.
Kienitz MC; Littwitz C; Bender K; Pott L
Basic Res Cardiol; 2011 Nov; 106(6):953-66. PubMed ID: 21681579
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of muscarinic K+ current in guinea-pig atrial myocytes by PD 81,723, an allosteric enhancer of adenosine binding to A1 receptors.
Brandts B; Bünemann M; Hluchy J; Sabin GV; Pott L
Br J Pharmacol; 1997 Jul; 121(6):1217-23. PubMed ID: 9249260
[TBL] [Abstract][Full Text] [Related]
10. Structural requirements of sphingosylphosphocholine and sphingosine-1-phosphate for stimulation of activator protein-1 activity.
Berger A; Bittman R; Schmidt RR; Spiegel S
Mol Pharmacol; 1996 Sep; 50(3):451-7. PubMed ID: 8794881
[TBL] [Abstract][Full Text] [Related]
11. G protein-independent inhibition of GIRK current by adenosine in rat atrial myocytes overexpressing A1 receptors after adenovirus-mediated gene transfer.
Bösche LI; Wellner-Kienitz MC; Bender K; Pott L
J Physiol; 2003 Aug; 550(Pt 3):707-17. PubMed ID: 12815176
[TBL] [Abstract][Full Text] [Related]
12. Development of a Diagnostic Screening Strategy for Niemann-Pick Diseases Based on Simultaneous Liquid Chromatography-Tandem Mass Spectrometry Analyses of N-Palmitoyl-O-phosphocholine-serine and Sphingosylphosphorylcholine.
Iwahori A; Maekawa M; Narita A; Kato A; Sato T; Ogura J; Sato Y; Kikuchi M; Noguchi A; Higaki K; Okuyama T; Takahashi T; Eto Y; Mano N
Biol Pharm Bull; 2020 Sep; 43(9):1398-1406. PubMed ID: 32581190
[TBL] [Abstract][Full Text] [Related]
13. Increased Levels of Sphingosylphosphorylcholine (SPC) in Plasma of Metabolic Syndrome Patients.
El-Najjar N; Orsó E; Wallner S; Liebisch G; Schmitz G
PLoS One; 2015; 10(10):e0140683. PubMed ID: 26466367
[TBL] [Abstract][Full Text] [Related]
14. Sphingosylphosphorylcholine, a naturally occurring lipid mediator, inhibits human platelet function.
Altmann C; Meyer Zu Heringdorf D; Böyükbas D; Haude M; Jakobs KH; Michel MC
Br J Pharmacol; 2003 Feb; 138(3):435-44. PubMed ID: 12569068
[TBL] [Abstract][Full Text] [Related]
15. Effect of sphingosine derivatives on calcium fluxes in thyroid FRTL-5 cells.
Törnquist K; Ekokoski E
Biochem J; 1994 Apr; 299 ( Pt 1)(Pt 1):213-8. PubMed ID: 8166643
[TBL] [Abstract][Full Text] [Related]
16. [Muscarinic modulation of cardiac activity].
Sauviat MP
J Soc Biol; 1999; 193(6):469-80. PubMed ID: 10783705
[TBL] [Abstract][Full Text] [Related]
17. The multi-functional role of sphingosylphosphorylcholine.
Nixon GF; Mathieson FA; Hunter I
Prog Lipid Res; 2008 Jan; 47(1):62-75. PubMed ID: 18042469
[TBL] [Abstract][Full Text] [Related]
18. Sphingosylphosphorylcholine enhances calcium entry in thyroid FRO cells by a mechanism dependent on protein kinase C.
Afrasiabi E; Blom T; Ekokoski E; Tuominen RK; Törnquist K
Cell Signal; 2006 Oct; 18(10):1671-8. PubMed ID: 16490345
[TBL] [Abstract][Full Text] [Related]
19. Ca2+ and voltage dependence of cardiac ryanodine receptor channel block by sphingosylphosphorylcholine.
Yasukochi M; Uehara A; Kobayashi S; Berlin JR
Pflugers Arch; 2003 Mar; 445(6):665-73. PubMed ID: 12632186
[TBL] [Abstract][Full Text] [Related]
20. Ca2+ signaling induced by sphingosylphosphorylcholine and sphingosine 1-phosphate via distinct mechanisms in rat glomerular mesangial cells.
Chen PF; Chin TY; Chueh SH
Kidney Int; 1998 Nov; 54(5):1470-83. PubMed ID: 9844123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
